CD4+CD25+ regulatory T-cells: a potential target for treating patients with chronic HBV infection

Jiezuan Yang1, Lanjuan Li1

  • 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Abstract

No abstract available in PubMed .

Related Concept Videos